AT
WST icon

Arlington Trust’s West Pharmaceutical WST Stock Holding History

Arlington Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.2K Hold
162
– – ﹤0.01% 249
2026
Q1 		$40.6K Buy
+162
New +$40.3K ﹤0.01% 244
2024
Q1 		– Sell
-2
Closed -$704 – 898
2023
Q4 		$704 Buy
+2
New +$708 ﹤0.01% 866

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
BZWA
Blue Zone Wealth Advisors Los Angeles, California $573M AUM 22.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Arlington Trust's WST Position: Q2 2026 in Review

Arlington Trust held its West Pharmaceutical (WST) position steady in Q2 2026 at 162 shares worth $58.2K. The position accounts for ﹤0.01% of the portfolio, ranked #249.

Arlington Trust first reported a position in WST in Q4 2023 and has held it in 3 quarters since. 120 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Arlington Trust held 162 shares of West Pharmaceutical worth $58.2K as of Q2 2026.
  • Arlington Trust left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #249 holding.
  • Arlington Trust first reported a position in West Pharmaceutical in Q4 2023 and has held it in 3 quarters since.
  • 120 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.